My SEQUENOM
|
Careers
|
Contact Us
|
Home
Harry Stylli
Charles Cantor
Robert M. Di Tullio
Betty Dragon
Paul Hawran
Alisa Judge
Michael Monko
Larry Myres
Clarke Neumann
Steven Owings
Overview
Mission
Leadership Team
Locations and Contact
iPLEX Genotyping
QGE Gene Expression
EpiTYPER DNA Methylation Analysis
iSEQ Molecular Typing
Hardware and Options
Overview
Service Business Infrastructure
Labratory Information Management System
Our Expertise
Our Offerings
Project Sequence and Timeline
Applications
Systems
Genetic Services
Introduction
Fetal Nucleic Acid Technology
Information on RhD
Introduction
Press Releases
Contact Us
Terms & Conditions
Noninvasive Prenatal Diagnostics
SEC Filings
Financial Reports
Corporate Governance
Fundamentals
Earnings Estimates
Ownership Summary
Webcasts & Events
Stock Information
Information Request
Jobs
Benefits
Development
Diversity
Activities & Services
Recruiter Message
News
Events
Investor Relations
Careers
Scientific Publications
Intellectual Property
Corporate Governance
iPLEX Genotyping
QGE Gene Expression
EpiTYPER DNA Methylation Analysis
Genotyping FAQs
QGE FAQs
EpiTYPER FAQs
Overview
Training and Upcoming Events
FAQs
Ordering Information
Contact Support
Overview
About Us
Genetic Analysis
Diagnostics
Corporate
Support
Assays By Sequenom
Diagnostics
Noninvasive Prenatal Diagnostics
Noninvasive Prenatal Diagnostics
Introduction
Fetal Nucleic Acid Technology
Information on RhD
Introduction
Press Releases
Contact Us
Terms & Conditions
Press Releases
Access the following announcements for the most up-to-date information about Sequenom.
3/17/08
Presentation at ACMG Meeting Supports Utility of Sequenom's SEQureDx Technology in Fetal Gender Determination
01/30/08
Sequenom and NAFNet to Conduct Fetal Rhesus D Study in Collaboration with Baylor College of Medicine
01/23/08
Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome
12/27/07
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
11/05/07
Sequenom to Sponsor Workshop Introducing Prenatal Diagnostics at AMP 2007 Annual Meeting
06/28/07
Lenetix Reports Submission of Clinical Data to New York State Authorities for the Commercial Launch of Non-Invasive Prenatal Rhesus D Incompatibility Test
05/08/07
Sequenom Announces Positive Clinical Data and Performance for the Fetal Rhesus D Genotyping Assay
02/13/07
Sequenom Expands Non-Invasive Prenatal Diagnostic Intellectual Property Portfolio
02/09/07
New Data Supports a Non-Invasive Approach to Routine Prenatal Genetic Testing
02/05/07
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
01/29/07
Sequenom and Lenetix Enter Agreement to Develop and Commercialize Rhesus D Prenatal Diagnostic
01/25/07
Sequenom to Present Scientific Poster at the Society of Maternal-Fetal Medicine Annual Meeting
01/08/07
Sequenom and QIAGEN Enter Into Collaboration Targeting Prenatal Diagnostics
11/02/07
Sequenom Benefits From Favorable Ruling in European Patent Office Opposition Proceeding
10/25/06
Sequenom Expands Non-Invasive Prenatal Diagnostic Testing Opportunity
05/17/06
Sequenom Hires Accomplished Diagnostics Executive Elizabeth (Betty) Dragon, Ph.D. to Lead Research and Development
03/27/06
Sequenom Reports Positive Outcomes from Two Siemens-Sponsored Molecular Diagnostic Research Studies of MassARRAY(R) Platform
10/23/05
Sequenom Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property
Copyright © 2005 SEQUENOM, Inc. All Rights Reserved. |
Terms & Conditions
|
Site Map